Decoy Therapeutics Inc. (DCOY) stock
DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.08 (-7.56%)
Close on Nov 13, 2026Market cap $638.94KP/E –Yield –
Decoy Therapeutics cash
Cash and short-term investments held at the end of each period.
Decoy Therapeutics's cash was $8.17M at Sep 30, 2026. For fiscal 2025 it was $10.71M, up 339.9% from the year before. Over ten years it grew -19.3% a year on average. The highest annual figure on record is $91.47M in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.71M | +339.9% |
| FY2024 | Dec 31, 2024 | $2.43M | -58.7% |
| FY2023 | Dec 31, 2023 | $5.90M | -51.3% |
| FY2022 | Dec 31, 2022 | $12.11M | -58.6% |
| FY2021 | Dec 31, 2021 | $29.21M | +162.8% |
| FY2020 | Dec 31, 2020 | $11.12M | +197.4% |
| FY2019 | Dec 31, 2019 | $3.74M | -39.0% |
| FY2018 | Dec 31, 2018 | $6.13M | -58.1% |
| FY2017 | Dec 31, 2017 | $14.65M | -76.1% |
| FY2016 | Dec 31, 2016 | $61.20M | -33.1% |
| FY2015 | Dec 31, 2015 | $91.47M | +170.2% |
| FY2014 | Dec 31, 2014 | $33.85M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.17M | +69.8% |
| Q2 FY2026 | Jun 30, 2026 | $8.29M | +942.8% |
| Q1 FY2026 | Mar 31, 2026 | $7.82M | +334.9% |
| Q4 FY2025 | Dec 31, 2025 | $10.71M | +339.9% |
| Q3 FY2025 | Sep 30, 2025 | $4.81M | +46.5% |
| Q2 FY2025 | Jun 30, 2025 | $794.89K | -75.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.80M | -58.9% |
| Q4 FY2024 | Dec 31, 2024 | $2.43M | -58.7% |
| Q3 FY2024 | Sep 30, 2024 | $3.28M | -56.7% |
| Q2 FY2024 | Jun 30, 2024 | $3.27M | -71.6% |
| Q1 FY2024 | Mar 31, 2024 | $4.37M | -52.8% |
| Q4 FY2023 | Dec 31, 2023 | $5.90M | -51.3% |
| Q3 FY2023 | Sep 30, 2023 | $7.58M | -54.9% |
| Q2 FY2023 | Jun 30, 2023 | $11.54M | -49.0% |
| Q1 FY2023 | Mar 31, 2023 | $9.27M | -61.7% |
| Q4 FY2022 | Dec 31, 2022 | $12.11M | -58.6% |
| Q3 FY2022 | Sep 30, 2022 | $16.82M | -47.3% |
| Q2 FY2022 | Jun 30, 2022 | $22.65M | -31.5% |
| Q1 FY2022 | Mar 31, 2022 | $24.19M | -33.9% |
| Q4 FY2021 | Dec 31, 2021 | $29.21M | +162.8% |
| Q3 FY2021 | Sep 30, 2021 | $31.90M | +233.8% |
| Q2 FY2021 | Jun 30, 2021 | $33.08M | +358.0% |
| Q1 FY2021 | Mar 31, 2021 | $36.61M | +279.5% |
| Q4 FY2020 | Dec 31, 2020 | $11.12M | +197.4% |
| Q3 FY2020 | Sep 30, 2020 | $9.56M | +139.0% |
| Q2 FY2020 | Jun 30, 2020 | $7.22M | +74.5% |
| Q1 FY2020 | Mar 31, 2020 | $9.65M | +67.2% |
| Q4 FY2019 | Dec 31, 2019 | $3.74M | -39.0% |
| Q3 FY2019 | Sep 30, 2019 | $4.00M | -33.9% |
| Q2 FY2019 | Jun 30, 2019 | $4.14M | -73.9% |
| Q1 FY2019 | Mar 31, 2019 | $5.77M | -75.9% |
| Q4 FY2018 | Dec 31, 2018 | $6.13M | -58.1% |
| Q3 FY2018 | Sep 30, 2018 | $6.05M | -84.5% |
| Q2 FY2018 | Jun 30, 2018 | $15.88M | -66.3% |
| Q1 FY2018 | Mar 31, 2018 | $23.95M | -54.7% |
| Q4 FY2017 | Dec 31, 2017 | $14.65M | -76.1% |
| Q3 FY2017 | Sep 30, 2017 | $38.93M | – |
| Q2 FY2017 | Jun 30, 2017 | $47.12M | – |
| Q1 FY2017 | Mar 31, 2017 | $52.81M | – |
| Q4 FY2016 | Dec 31, 2016 | $61.20M | – |
See a number that looks wrong?